Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
Community
/
United Kingdom
/
Pharmaceuticals & Biotech
Create a narrative
Haleon
LSE:HLN Community
1
Narratives
written by author
0
Comments
on narratives written by author
29
Fair Values set
on narratives written by author
Create a narrative
Haleon
Popular
Undervalued
Overvalued
Haleon
WA
Analyst Price Target
Consensus Narrative from 17 Analysts
Sensodyne IND 20 And Cost Savings Will Strengthen Future Market Position
Key Takeaways Haleon is driving growth through innovation and international expansion in emerging markets, enhancing market share and revenue. Strategic divestments and efficiency programs aim to boost profitability, operational efficiency, and shareholder value.
View narrative
UK£4.03
FV
2.8% overvalued
intrinsic discount
3.86%
Revenue growth p.a.
Set as Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
2 days ago
author updated this narrative
Your Valuation for
HLN
Haleon
Your Fair Value
UK£
Current Price
UK£4.15
1.2% undervalued
intrinsic discount
Growth estimate over
Annual revenue growth rate
5 Years
time period
%/yr
Decrease
Increase
Past
Future
0
14b
2015
2018
2021
2024
2025
2027
2030
Revenue UK£13.8b
Earnings UK£1.8b
Advanced
Set as Fair Value